Teva Pharmaceutical Industries Ltd (TEVA) stock saw a decline, ending the day at $20.94 which represents a decrease of $-0.55 or -2.56% from the prior close of $21.49. The stock opened at $21.27 and ...

Samsung Bioepis Co. and Teva Pharmaceutical Industries (TEVA have entered into a license, development and commercialization agreement ...

The US Court of Appeals for the Federal Circuit affirmed a district court’s delisting of patents from the Orange Book because the patent claims ...

Oppenheimer raised the firm’s price target on Catalyst Pharmaceuticals (CPRX) to $31 from $29 and keeps an Outperform rating on the shares.

We tested 24 winter boots for women from Baffin, Xero, Ugg and more, and three kept our toes toasty during the coldest months ...

Deep into Brooklyn by Gravesend, behind a trio of what seem to be nondescript gated doors, is a treasure of a kosher ...

Marks a step forward in broadening treatment options for patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical ...

Korean drugmakers hold over 50% market share in the 6 best-selling biosimilar markets, 2 companies sign exclusive licensing ...

Teva might be known for its sandals, but its new Trailwinder Hiking Shoe was great for dry land trail excursions. The post ...

Seeks ideas for investing fiscal year 2026 opioid settlement funds The Wisconsin Department of Health Services (DHS) awarded agencies in communities across the state more than $21 million from the ...

Sanofi’s Dupixent and new drugs drive growth, despite near-term pressures. See why SFY stock’s product pipeline makes it a ...